Live Breaking News & Updates on European medicines agency

Stay informed with the latest breaking news from European medicines agency on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in European medicines agency and stay connected to the pulse of your community

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Japan , United-states , China , Iceland , Macau , Panmure , Victoria , Australia , Hong-kong , Cairo , Al-qahirah , Egypt

Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A

/PRNewswire/ -- Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion...

Russia , Japan , Taiwan , Stockholm , Sweden , United-states , Australia , America , Lydia-abad-franch , Prnewswire-sobi , Linkedin , Committee-for-medicinal-products-human-use

Swedish Orphan Biovitrum AB: Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A

Swedish Orphan Biovitrum AB: Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , Stockholm , Sweden , Australia , Willebrand , Nordrhein-westfalen , Germany , Taiwan , Japan , Russia , America , Dennis-riedl

Roche: positive CHMP opinion for Alecensa

Roche announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Alecensa as monotherapy, as adjuvant therapy in patients with...

Levi-garraway , Head-of-global-product-development , European-medicines-agency , Medicinal-products , Human-use , Chief-medical-officer , Global-product ,

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer

− If Approved in the European Union, Fruquintinib Will Be the First Novel Targeted Therapy for Metastatic Colorectal Cancer Regardless of Biomarker Status in Over a Decade

− Positive Opinion...

Japan , Iceland , Norway , Cairo , Al-qahirah , Egypt , United-states , Macau , Australia , China , Hong-kong , Liechtenstein

Bristol Myers: positive opinion from the CHMP for Opdivo

Bristol Myers Squibb announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the approval of Opdivo in combination with cisplatin...

Dana-walker , Bristol-myers-squibb , European-union , Global-program-leader , European-medicines-agency , Committee-for-medicinal-products-human-use , European-commission , Medicinal-products , Human-use , Vice-president , Genitourinary-cancers , Bristol-myers

AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency...

Puerto-rico , Saudi-arabia , Brazil , United-states , Japan , Milano , Lombardia , Italy , Australia , Canada , United-kingdom , Great-britain

Positive CHMP Opinion for Fruquintinib | Company Announcement

Investegate announcements from Positive CHMP Opinion for Fruquintinib

Australia , China , Japan , Panmure , Victoria , United-states , Liechtenstein , Hong-kong , Norway , Iceland , Macau , American

Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza

By Colin Kellaher

Amgen plans to seek European regulatory approval for the sale of its blockbuster Tepezza treatment for thyroid eye disease.

The Thousand Oaks, Calif., biotechnology...

Colin-kellaher , European-medicines-agency , Drug-administration , Amgen , Thousand-oaks , Horizon-therapeutics , Dow-jones , Markets ,

Takeda Reports Positive CHMP Opinion For Fruquintinib

Takeda (TAK) announced the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors for the treatment of adult patients with previously treated metastatic colorectal cancer or mCRC.

More-such-health-news , European-medicines-agency , Medicinal-products , Human-use , Drug-administration , Fda , Akeda ,